Neurodivergent Women Leaders + Perimenopause in Silicon Valley
A conversation on Substack between Nicole Ohebshalom, PhD and Dr. Sarah
The Neurodivergent Leader
Nicole Ohebshalom, PhD
I’m sitting in session with a woman that runs an engineering organization over the last fifteen years, she led through an acquisition, a co-founder’s exit, and a few bad quarters. She’s good at her job, and she knows she’s good at this.
What is unseen is how much work goes into leading from a place that feels steady to her team.
She has ADHD, and the calm exterior runs on a system she has built for herself: the color-coded calendar, the morning brain-dump to organize her thoughts before the day starts so her focus is sharpest and a mid-day workout.
Over the decades, she built a structure that holds everything in her life up.
Then, sometime around forty, the structure starts to fail.
At first, it was hard for her to explain what was happening. The morning brain-dump stopped organizing her thoughts.
The sharp thinking didn’t show up at nine, or at two, or at her desk at all. When she came to me, she didn’t say the word “perimenopause.”
She says, I think something is wrong with me. I am not myself anymore. I’m not actually as capable as everyone thinks. I’ve been getting away with it. I feel like I’ve been caught.
Many women start with this conversation and not with a list of symptoms. It becomes a verdict they’ve already handed down on themselves.
She is using words that signal capability, but it’s really a capacity that has changed and needs readjustment.
Dr. Sarah
What she is describing is not a character defect or a professional unraveling. It is a diagnostic picture.
When a neurodivergent woman in her forties presents with sudden loss of her compensation strategies, new or worsening cognitive fog, and a deep certainty that she is finally being exposed as inadequate, perimenopause belongs on the differential.
Not as a last resort after everything else has been ruled out, but as a first and serious consideration.
The symptoms she is naming have a neurobiological explanation. Finding that explanation is the beginning of actual help.
2. What Perimenopause Is in the Context of Neurodivergent Technical Leadership
Dr. Sarah
Perimenopause is not a single event. It is a hormonal transition that typically begins in the early to mid-forties, though it can start earlier, and it can run for anywhere from two to twelve years before the final menstrual period.
What defines it is not the absence of periods but the variability: estrogen and progesterone stop cycling in a predictable pattern and begin to fluctuate, sometimes wildly, before they eventually decline.
For neurotypical women, this transition is disruptive. For neurodivergent women, it is often destabilizing in a way that feels categorically different, and it is.
Here is the part that most clinical conversations skip:
estrogen is not a reproductive hormone with some cognitive side effects.
Estrogen is a neuroactive steroid. It directly shapes dopamine and serotonin activity, the same neurotransmitter systems that are already running differently in ADHD and autism.
When estrogen fluctuates unpredictably across perimenopause, it does not just add a new layer of symptoms on top of an existing neurodivergent profile.
It destabilizes the chemical environment the neurodivergent brain has been adapting to and compensating within for decades.
The woman sitting across from you did not suddenly develop cognitive dysfunction.
The neurological substrate she built her entire professional life on top of just changed, without warning, without a clear timeline, and without any acknowledgment from most of the systems medical, workplace, cultural that were supposed to help her navigate it.
In my practice, I see this play out in a specific way for women in leadership.
They are already operating at the edge of their compensation strategies.
They have spent twenty years learning exactly how to make their brain work in an environment that was not built for it.
That knowledge is real and hard-won and it works, until the hormonal conditions it was built on shift.
What they are experiencing is not cognitive decline.
It is not burnout, though burnout often accompanies it.
It is not impostor syndrome, though the internal narrative of impostor syndrome is loud and familiar and lands hard when the strategies stop working.
It is a neurological transition occurring on top of a neurodivergent baseline, in a high-stakes professional context, with almost no clinical framework designed to account for that combination.
That is the starting point. Everything else follows from naming it correctly.
3. The Neurobiology
Dr. Sarah
To understand why perimenopause hits neurodivergent women differently, you need to understand what these hormones are doing in the brain.
We are not talking about reproductive hormones with some cognitive side effects.
We are talking about neuroactive steroids that directly shape the chemical environment the neurodivergent brain has been adapting to and compensating within for decades.
Estrogen and the dopamine system
Dopamine is central to ADHD. It governs executive function, working memory, motivation, and the ability to initiate tasks.
Estrogen upregulates dopamine receptor sensitivity and supports dopamine synthesis in the prefrontal cortex.
When estrogen levels are stable and adequate, the dopamine system runs more efficiently.
When estrogen drops or fluctuates, as it does throughout perimenopause, dopamine signaling becomes less reliable.
For a neurotypical woman, this is noticeable.
For a woman with ADHD whose dopamine system was already running on a narrower margin, it is immediately and significantly impairing.
The working memory that was functional with the right systems in place becomes unreliable.
Task initiation, already effortful, becomes harder. The processing speed that allowed her to keep up in a fast-moving leadership environment slows.
This is not subjective. The neurobiology is consistent with what she is reporting.
Estrogen and the serotonin system
Serotonin regulates mood, emotional stability, and sensory processing. Estrogen supports serotonin synthesis and receptor sensitivity.
As estrogen fluctuates in perimenopause, serotonin regulation becomes less stable.
For autistic women and women with sensory processing differences, this matters in a specific way.
Sensory tolerance the ability to manage fluorescent lights, open-plan offices, constant Slack notifications, and the physical and social demands of being in a room with thirty people all day is partially regulated by serotonin.
When that regulation becomes less stable, sensory tolerance drops.
The environment that was manageable becomes harder to be in.
The masking that was costly becomes more costly, and then unsustainable.
This is also where emotional reactivity lives.
In clinical practice I see women describing a new or worsened anxiety that feels different from what they have experienced before: more physical, more reactive, less responsive to the cognitive strategies that used to help.
For women with rejection-sensitive dysphoria, the threshold for perceived threat drops further. Feedback that was manageable becomes harder to receive.
The emotional regulation that took years to develop requires a stable serotonin environment to execute, and that environment is no longer stable.
Progesterone and the nervous system
Progesterone is often left out of this conversation and it should not be.
Progesterone metabolizes into allopregnanolone, a neurosteroid that binds to GABA receptors and produces a calming, anti-anxiety effect on the nervous system.
When progesterone is adequate, it acts as a natural buffer against stress reactivity and supports deep, restorative sleep.
In perimenopause, progesterone is often the first hormone to decline significantly, and it declines in an unpredictable pattern.
For neurodivergent women whose nervous systems are already running closer to the edge of their window of tolerance, the loss of that GABAergic buffer is not subtle.
Sleep becomes fragmented and unrestorative.
The nervous system loses a layer of its natural regulation.
The internal experience is often described as a baseline hum of dread or unease that was not there before, or a sensitivity to stress that feels completely out of proportion.
That is not anxiety as a psychological phenomenon.
That is the nervous system without its progesterone floor.
Testosterone and cognitive drive
Testosterone in women is produced in the ovaries and adrenal glands and declines across the perimenopause years, often before estrogen does.
It is almost never mentioned in standard perimenopause conversations, but for neurodivergent women in high-performance roles it is clinically relevant.
Testosterone supports dopamine activity, motivation, mental stamina, and the drive to initiate and complete complex tasks.
For a woman with ADHD who relies heavily on interest-based motivation and has always needed more activation energy than her neurotypical peers, declining testosterone removes another layer of the neurochemical support that was keeping her functional.
She does not just feel tired. She feels like she cannot find the engine.
The work that used to feel compelling starts to feel like pushing through wet concrete, even when nothing about the work itself has changed.
Low testosterone also contributes to low mood, reduced confidence, and a flattening of the sense of reward that comes from doing work well.
In a population already vulnerable to impostor syndrome and shame about performance, this matters.
Sleep and the cascade effect
Perimenopause disrupts sleep through night sweats, declining progesterone, increased cortisol at night, and reduced slow-wave sleep.
Sleep deprivation impairs the prefrontal cortex, the brain region responsible for executive function, emotional regulation, and impulse control.
For a neurodivergent woman who is already managing executive function differences, adding chronic sleep disruption to fluctuating hormones creates a compounding impairment.
The strategies that required cognitive effort to implement become harder to access precisely when she needs them most.
The emotional regulation that took years to develop requires a functioning prefrontal cortex to execute.
When sleep is gone, the whole system runs hotter and breaks down faster.
This is the neurobiology of the Scaffolding Collapse. It is not metaphor. It is mechanism.
A note on the clinical gap
The research on perimenopause and neurodivergence is early. Most of what we know about perimenopausal cognitive changes comes from studies on neurotypical women.
The specific intersection of ADHD, autism, and perimenopausal hormone fluctuation is understudied. I flag this because it matters: when a patient comes in with this profile, she is often ahead of the existing clinical literature.
Her experience is real and it has a clear neurobiological basis, but the data to tell her exactly what to expect and exactly what will help is still being built.
Honest medicine names that gap rather than filling it with false certainty.
4. How It Shows Up in the Therapy Chair and the Silicon Valley Overlay
Nicole Ohebshalom, PhD
By the time one of these leaders sits down across from me, she’s usually already diagnosed herself. The diagnosis is personal failure.
I want to name that first, because it colors everything that comes after: she doesn’t experience the cognitive changes of perimenopause as a medical event. She experiences them as getting caught.
Perimenopause changes the chemistry. And when it does, every workaround gets more costly at once.
It is difficult to internally see this change: the strategies didn’t stop working because she got lazy or lost her edge. They stopped working because the conditions they were built on shifted underneath her.
There becomes a frightening sense of cognitive slipping: words vanishing mid-sentence, walking into rooms with no memory of why, losing track of conversations, and a brain fog so thick they wonder if they’re developing early dementia.
Now add the industry she’s in. Tech leadership prizes exactly the abilities perimenopause tends to destabilize.
It is based on fast recall, long stretches of sprint-level focus, jumping between a dozen Slack threads without losing any of them, staying even-keeled while everything escalates around her.
The culture has no concept of capacity that rises and falls. It barely acknowledges that a leader has a body at all. The always-on expectation was already hard on anyone whose focus naturally fluctuates.
Now hers is fluctuating in a new and frightening way, in a field that treats a person like a machine you log into.
Many women moving through perimenopause often experience a destabilizing rupture in their sense of self.
As estrogen declines and dopamine regulation falters, that scaffolding begins to fail, and what surfaces is not just symptoms but a profound threat to who they believe themselves to be.
There’s often a disorienting gap between the internal self-image of someone capable and “on top of it” and the lived reality of forgetting, fumbling, and falling behind — a gap that generates shame, self-doubt, and a quiet panic that the “real” disorganized self they always feared was lurking underneath is finally breaking through.
Old internalized voices, frequently the critical messages absorbed in childhood from parents, teachers, or peers who labeled them lazy, careless, or “not living up to potential,” come roaring back with renewed authority, now seemingly confirmed by present struggles.
This can reactivate earlier developmental wounds, collapsing the felt distance between the competent adult and the child who was constantly reprimanded. Many describe a grief that operates on multiple levels at once: mourning the loss of cognitive sharpness, mourning the version of themselves they had worked so hard to become, and, for those diagnosed late, mourning the decades spent not knowing, the relationships strained, and the self-blame carried needlessly.
There’s frequently a loss of trust in one’s own mind, an unsettling sense that the internal instrument used to navigate the world can no longer be relied upon, which breeds hypervigilance and anticipatory anxiety.
Underneath much of it runs a painful question of whether they were ever truly competent at all, or merely compensating, and a fear that the compensation has finally run out.
A Note on Identity
The identity rupture sits at the core of the perimenopausal experience for many women with ADHD, and it cuts deeper than symptom severity alone can explain.
For decades, these women have often related to themselves through a particular organizing story:
I am someone who manages, who pushes through, who has figured out how to make my brain work despite the friction. This narrative is not merely self-description but a load-bearing structure of the psyche, the thing that allowed them to feel acceptable, to silence the early fear that they were fundamentally flawed.
The compensatory self, built through immense and largely invisible effort, came to feel like the true self, or at least a self they could stand behind.
When perimenopause erodes the neurological conditions that made that compensation possible, the rupture is not experienced as “my symptoms got worse” but as “I am losing the person I made myself into.”
What makes this so destabilizing is that the competent identity was, for many, a defense against a more primitive and dreaded self-state — the disorganized, “too much,” forgetful, unreliable child who was perpetually in trouble and could not understand why.
That earlier self was often split off, disowned, and held at bay precisely through achievement and control. As the controlling structures fail, the split-off self threatens to return, and with it the unbearable affects it carried: shame, defectiveness, the terror of being exposed as fraudulent.
This is why many women describe the experience not as decline but as unmasking — a sense that the capable persona was always a performance and now the curtain is being pulled back to reveal who they “really” are.
The phrase impostor feeling takes on a literal psychic weight here; the fear is not of being caught faking competence but of discovering that competence itself was never theirs to keep.
There is also a temporal collapse involved. The competent adult self exists in a kind of forward-moving narrative of growth and accumulating mastery, and the rupture throws the woman backward into an earlier developmental position where she felt helpless and bad.
The continuity of identity across time — the felt sense that I am the same person who built all this — fractures. Some describe a doubling: a part that still holds the old self-image and a part flooded by the returning younger self, with neither feeling fully real.
The work of mourning here is not only grief over lost function but grief over the loss of a hard-won self-concept, and, more hopefully, the possibility of constructing an identity that no longer depends on relentless compensation, that can hold both the capable and the struggling parts without one having to annihilate the other.
5. The Scaffolding Collapse: Our Shared Frame
Nicole Ohebshalom, PhD and Dr. Sarah
Perimenopause for neurodivergent leaders is a Scaffolding Collapse. To understand: Picture each person’s functioning as a building.
When a neurotypical woman reaches perimenopause, she loses something real, call it one floor of a ten-story building. It’s disruptive and it matters, but the building still stands.
A neurodivergent woman has spent her whole life building scaffolding around her building, because the building on its own was never quite enough to meet what the world expected of her.
Over time, that scaffolding stops being an add-on and becomes part of how she functions.
So when perimenopause arrives, it doesn’t take one floor. It comes for the scaffolding: the focus workarounds, the emotional-regulation strategies, the memory systems, and it comes for a lot of it at once.
This is why her experience feels so out of proportion to what she’s told to expect, and why she feels half-crazy when a doctor says, “Plenty of women your age feel a little foggy.” She isn’t losing one floor.
She’s watching the entire external structure she built the thing that let her pass in a world set up for other brains come down in a pile.
The collapse isn’t bigger because she’s weaker. It’s bigger because she had more scaffolding to lose. And the hardest part is that the scaffolding was invisible the whole time. It was invisible to her colleagues, often to her, sometimes even to the doctors she finally works up the nerve to ask for help.
It’s very hard to grieve, or rebuild, something no one ever agreed was there.
A good amount of what comes down in the Scaffolding wasn’t holding her up at all. It was holding her in. Some of that scaffolding was the performance: the agreeableness she learned to lead with, the meetings she sat through pretending the dysfunction was fine, the version of herself she assembled each morning to be palatable to the room. When that goes, it doesn’t only register as loss.
They no longer have the capacity for other people’s nonsense and underneath the apology, they mean it as relief and clarity.
Perimenopause doesn’t just take the systems that were keeping her functioning. It takes the energy she’d been spending to seem fine, to smooth things over, to stay easy to be around.
And when there isn’t enough left to fund all that performance, what’s underneath turns out to be a clear sense of who she actually is and what she will and won’t do anymore. The collapse exposes her. It also, sometimes, returns her to herself.
The neuroendocrine piece
Dr. Sarah
What Nicole describes as scaffolding collapsing has a precise hormonal explanation. It is not one hormone dropping.
It is three hormones shifting in sequence, each taking out a different layer of the foundation this woman has been standing on.
Progesterone goes first. It typically begins declining in the late thirties, often before a woman has any idea perimenopause is on the horizon.
Progesterone is her nervous system’s natural buffer.
It is what kept the baseline hum manageable, what allowed her to sleep deeply enough to recover, what gave her nervous system a floor. When it starts to drop, the first thing she usually notices is that sleep is less restorative.
Then her anxiety has a different texture than before.
Then she is less tolerant of the things she used to absorb without much effort.
She often attributes this to stress, or getting older, or the demands of her role. It rarely occurs to her or her doctor that her progesterone is already in decline.
Then estrogen becomes erratic. This is the part that is most misunderstood.
Perimenopause is not a smooth downward slope.
Estrogen surges and crashes, sometimes dramatically, sometimes within the same week.
For a neurodivergent nervous system that depends on predictability and has spent decades building routines calibrated to a relatively stable internal environment, this variability is uniquely destabilizing.
It is not just that estrogen is lower. It is unpredictable. The brain cannot adapt to a moving target.
The scaffolding she built was designed for a consistent environment. It was not built for one that changes without warning.
Testosterone declines quietly throughout this entire process, often going unnoticed and untested.
There is no dramatic crash, no signature symptom that flags it clearly. What she notices instead is a gradual loss of drive.
The work that used to feel compelling starts to feel optional. The confidence that came from doing hard things well starts to feel less available.
The motivation to push through and figure it out which was always one of her most reliable assets becomes harder to locate. By the time she connects this to hormones at all, it has usually been declining for years.
The reason the collapse feels sudden and total rather than gradual is that these three hormones do not fail independently.
They fail in sequence and in combination, and the scaffolding she built was downstream of all of them.
When progesterone drops, she loses her nervous system floor. When estrogen becomes erratic, she loses her cognitive consistency.
When testosterone declines, she loses her drive and her sense of reward. Each loss compounds the others.
The strategies that required a calm nervous system, consistent cognition, and sufficient motivation to execute stop working not one at a time but all at once.
This is the hormonal architecture of the Scaffolding Collapse.
The scaffolding was real. The loss is real.
And the path back starts with understanding exactly what came down and why, so that what gets rebuilt is designed for the hormonal reality she is living in now, not the one she had before.
7. What Helps
Nicole Ohebshalom, PhD
Start by naming it as a change in the system, not a flaw in her character.
It is useful to stop asking what is wrong with me and start asking what changed, and what did it cost me. That shift, on its own, lifts an enormous amount of shame, and the shame was doing more damage than the fog ever did.
Give her permission in how to allocate her time.
You’re allowed to protect your best thinking hours the way you’d protect anything else that’s critical. You’re allowed to tell your calendar the truth about what you can do.
Rebuild the scaffolding rather than staying in mourning.
Build new structure for the brain, which usually means more external support and letting go of the idea that a “real” leader shouldn’t need any.
Treat the overlapping conditions as real and separate.
The fog, the anxiety, the low mood aren’t all perimenopause, and they aren’t all ADHD. Telling them apart is important because it creates clinical options. This isn’t about willpower.
Make room for the self that is surfacing, instead of managing it back down.
When the capacity for performance runs out, a truer version of her tends to show up: more direct, less willing to absorb dysfunction, clearer about what she actually wants her work and her days to be.
Her first instinct is usually to treat that as another symptom to control, because it’s inconvenient and it scares her. Often the bluntness and the low tolerance for nonsense aren’t the problem to be fixed, they’re information she’s never let herself have.
The work isn’t to get the old, more accommodating version back online. It’s to figure out which parts of who she’s becoming she wants to keep, and to build the new scaffolding around that person rather than the one she used to perform.
The medical options
Dr. Sarah
The medical conversation for this population has to start from the right baseline: neurodivergent women are not just managing perimenopausal symptoms.
They are managing the intersection of those symptoms with a neurodivergent nervous system that is already running differently, and in many cases already supported by medications whose behavior changes when the hormonal environment shifts.
Hormone therapy
Hormone therapy, particularly estrogen, is the most effective intervention available for perimenopausal cognitive symptoms, mood instability, and sleep disruption. For neurodivergent women whose estrogen decline is directly impacting dopamine and serotonin regulation, this is not a peripheral consideration. It is central.
The evidence base for hormone therapy has been significantly revised since the Women’s Health Initiative data from the early 2000s was initially reported.
Current guidance from major menopause societies supports the use of hormone therapy for symptoms where there are no contraindications. The risks look different for a 44-year-old in early perimenopause than they do for a 65-year-old.
Those conversations need to be individualized.
For this population specifically, I look closely at: transdermal estrogen, which avoids first-pass liver metabolism and provides more stable serum levels than oral forms; bioidentical progesterone for women with a uterus, which has a more favorable neurological profile than synthetic progestins and supports sleep and GABA activity; and the timing and delivery of hormone support relative to where she is in the perimenopausal transition.
I flag this clearly: hormone therapy is not right for every woman. Contraindications include certain hormone-sensitive cancers, active cardiovascular disease, and other individual risk factors. This is a conversation with a qualified provider who knows the full picture, not a protocol applied uniformly.
ADHD medication review
For women on stimulant medications for ADHD, perimenopause frequently requires a medication review.
The efficacy of stimulants is partly mediated by the dopamine environment they’re operating in.
When estrogen-supported dopamine signaling declines, stimulant medications that were working at a stable dose may become less effective, or may need to be adjusted. This is a recognized clinical pattern.
It is not tolerance in the traditional sense. It is the same medication operating in a different neurochemical environment.
If a patient reports that her ADHD medication stopped working around the same time other perimenopausal symptoms appeared, that is clinically significant information.
It warrants a review of both the medication and the hormonal picture together, not separately.
Sleep
Sleep disruption in perimenopause is not just a comfort issue.
For neurodivergent women managing executive function differences, chronic sleep deprivation is a clinical problem that compounds every other symptom.
Addressing the hormonal drivers of sleep disruption night sweats, cortisol dysregulation, reduced slow-wave sleep is often more effective than sleep hygiene alone. Magnesium glycinate, addressed estrogen levels where appropriate, and in some cases low-dose progesterone for its GABAergic effects are tools I use in practice.
Thyroid
Thyroid dysfunction becomes more common in the perimenopause years and the symptom overlap is significant enough that it cannot be skipped.
An underactive thyroid produces cognitive fog, fatigue, low mood, weight changes, and slowed processing speed.
An overactive or dysregulated thyroid produces anxiety, sleep disruption, and emotional instability.
Both presentations overlap almost completely with perimenopausal symptoms and with the dysregulation profile of ADHD.
If thyroid function is off, no amount of hormone therapy or ADHD medication adjustment will fully compensate for it.
I check a full thyroid panel in this population: TSH, free T3, free T4, reverse T3, and thyroid antibodies.
TSH alone is not sufficient.
A woman can have a TSH in the normal reference range and still have suboptimal free T3 conversion or elevated reverse T3 that is impairing her cognitive function.
Hashimoto’s thyroiditis, an autoimmune thyroid condition, also becomes more common in the perimenopause years and will not show up without antibody testing.
I want the full picture.
Ferritin and iron
Ferritin is the storage form of iron and it is one of the most commonly missed contributors to cognitive and energy symptoms in this population.
Standard lab reference ranges flag ferritin as low at levels around 12 to 15. In my practice I treat to a minimum of 70.
Below that threshold, many women experience fatigue, brain fog, poor sleep, restless legs, and reduced dopamine synthesis — because iron is a required cofactor in dopamine production.
For a woman with ADHD who is already dopamine-dependent, low ferritin is not a minor finding. It is a direct hit to the system she is trying to run on.
Heavy or irregular periods during perimenopause make this worse.
Many women are quietly losing iron every month without replacing it, and their ferritin has been low for years.
Checking it and treating it to an optimal level not just a reference range minimum is a basic and frequently overlooked intervention.
Mitochondrial support
Mitochondria produce the energy that every cell in the body runs on, including every neuron.
In perimenopause, declining estrogen directly affects mitochondrial function: estrogen supports mitochondrial biogenesis and efficiency, and as it drops, cellular energy production becomes less reliable.
For neurodivergent women who are already working harder than their neurotypical peers to perform the same cognitive tasks, reduced mitochondrial output is not an abstract concern. It is felt as a new and frustrating ceiling on what they can do in a day.
I support mitochondrial function through targeted nutrition and supplementation.
CoQ10 is a core cofactor in the mitochondrial energy chain and declines with age. Magnesium is required for hundreds of enzymatic reactions including ATP production and is commonly depleted in high-stress, high-output women.
B vitamins, particularly B12 and B6, support both mitochondrial function and neurotransmitter synthesis.
None of these are dramatic interventions. Together they address a real and measurable gap in the energy substrate the brain is trying to run on.
Other contributors worth evaluating include vitamin D and omega-3 fatty acids, both of which affect neuroinflammation and neurotransmitter function and are commonly low in women who have been high-output for decades without adequate replenishment.
A note on hormone therapy in neurodivergent women
Hormone therapy for neurodivergent women requires a different approach than standard protocols. The ND nervous system is more sensitive to hormonal shifts in both directions.
What feels like a therapeutic dose for a neurotypical woman can feel activating, destabilizing, or simply wrong for a woman whose nervous system is already finely tuned to its internal environment.
Starting low and going slow is not optional in this population. It is the protocol.
This means smaller starting doses, longer adjustment periods, and more frequent check-ins than a standard hormone therapy patient might need.
It means listening carefully when she says something feels off, because her nervous system will often detect a change before any lab value reflects it. Titrating hormones for an ND woman is a collaborative process.
It takes longer. It requires more precision. And it is worth doing carefully rather than quickly.
I also want to be honest about the limits of what hormone therapy can do.
For neurodivergent women, hormones are an important piece of the picture often a significant one but they are rarely the whole answer. The ADHD does not go away when estrogen is optimized.
The sensory sensitivities do not disappear when progesterone is restored. The decades of masking and compensation do not resolve because testosterone is back in range.
What hormone therapy does is restore the neurochemical floor the baseline stability that makes everything else more possible.
It creates conditions in which her other tools, therapeutic, structural, relational, can actually work again. That is meaningful. It is also not the finish line.
Some women will also find that addressing the hormonal piece surfaces things that were previously masked by the effort of just keeping up.
When the nervous system is no longer in crisis mode, there is sometimes space for grief, for reassessment, for a clearer look at what she actually wants her life and work to look like.
That is not a side effect. That is part of the process.
What I tell patients
You are not imagining this. You are not losing your mind. You are not finally being exposed as less capable than people thought.
Your brain is running on a different hormonal substrate than it was two years ago, and the strategies you built for that substrate need to be rebuilt for this one.
That is a clinical problem with clinical tools. It is also real work, and it takes time, and the timeline is not linear.
The goal is not to get back to who you were before.
It is to understand who you are now, with the neurological profile you have, in the hormonal transition you’re in, and to build from that reality rather than against it.
The scaffolding did not fail because she was not strong enough to hold it up. It failed because the ground shifted.
The work now is not to rebuild what was there before. It is to build something designed for the terrain she is actually standing on and to do that with the same rigor and honesty she has brought to every other hard problem in her career.
If you are reading this and recognizing yourself in the fog, the shame, the quiet certainty that you have finally been found out we want you to hear this clearly: you are not falling apart.
You are standing in the middle of a neurological transition that medicine is only beginning to understand, with almost no roadmap and almost no one around you who can name what is happening.
That is not a personal failure.
That is a gap in the system.
And it is one we can start to close.